This article is part 2 in our Smart Patients Blog Series Smart Patients Blog Series 1 of 5: Dr. Gilbert Discusses Early Symptoms of Parkinson’s Some early symptoms of Parkinson’s disease (PD) can begin many years before the classic motor symptoms (slowness, stiffness, tremor) ever appear. Symptoms such as sleep disturbances, loss of smell, constipation, […]
A major milestone has been reached as Japan has approved the world’s first stem-cell-based therapy for Parkinson’s disease (PD). The innovation was developed by Sumitomo Pharma in collaboration with Dr. Jun Takahashi at Kyoto University. This treatment represents a new approach that could potentially restore lost brain cells of PD. How it Works Dr. Takahashi […]
On a recent episode of APDA’s Dr. Gilbert Hosts, Dr. Gilbert spoke with Dr. Malu Gamez Tansey, the James A. Caplin, MD Chair in Alzheimer’s Disease at Indiana University School of Medicine and Director of Neuroimmunology Research Group, with expertise in the relationship between gut inflammation and Parkinson’s disease (PD). We covered a lot of ground […]
Dr. Gilbert chats with Dr. Okeanis Vaou about how climate may affect PD Living with Parkinson’s disease (PD) often means learning to adapt to changes in movement, thinking, and overall health. What many people don’t realize is that the environment, particularly temperature, humidity, and altitude—can also have a significant effect on symptoms. Recently, APDA’s Chief […]
What is Young Onset Parkinson’s Disease? When Parkinson’s disease (PD) is diagnosed between the ages of 21 and 50, it is called young onset, or early onset Parkinson’s disease (YOPD). Though symptoms overlap with typical PD, younger people face unique challenges, and even some surprising advantages, in managing the disease. Who Gets Young Onset […]
Exploring the New Forms of Carbidopa/Levodopa with Dr. Vaou On a recent episode of APDA’s Dr. Gilbert Hosts, I spoke with Dr. Okeanis Vaou, a movement disorders specialist, about the various new formulations of carbidopa/levodopa that are available, including Crexont® and Vyalev®, among others. Carbidopa/levodopa is the mainstay of treatment for Parkinson’s disease (PD) and is […]
APDA helps the Parkinson’s community live life to the fullest in April and year-round. With a diagnosis every six minutes, public awareness and support are crucial. NEW YORK, NY, MARCH 11, 2025 – April is Parkinson’s Disease Awareness Month, and the American Parkinson Disease Association (APDA) will commemorate the month with a “Did You Know?” […]
The SPARX3 Research Trial Investigates How Exercise Helps Parkinson’s People with Parkinson’s disease (PD) are constantly being told, by family, friends, doctors and the APDA community, that exercise is a vital part of any Parkinson’s treatment plan and is essential to functioning at your best with PD. To support this claim, there are many clinical […]
Exploring Vision Changes in Parkinson’s Disease Insights from Dr. Gilbert Hosts with Dr. Janet Rucker Vision changes are a common but often under-discussed non-motor symptom of Parkinson’s disease. These changes can include eye movement problems, dry eyes, visual hallucinations, and more. On a recent episode of APDA’s Dr. Gilbert Hosts, we spoke with Dr. Janet Rucker, […]
FROM STIGMA TO SUPPORT: RETHINKING MENTAL HEALTH IN THE PD COMMUNITY Tremors, rigidity, and mobility issues are commonly associated with Parkinson’s disease (PD). However, beneath the visible symptoms are many non-motor symptoms that are not always outwardly noticeable. One of these quieter yet equally important aspects of this disease are the mental health challenges that […]
